Wave Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Wave Life Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. 

CEO
Paul B. Bolno
CEOPaul B. Bolno
Employees
317
Employees317
Headquarters
Singapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded
2012
Founded2012
Employees
317
Employees317

WVE Key Statistics

Market cap
1.20B
Market cap1.20B
Price-Earnings ratio
-5.25
Price-Earnings ratio-5.25
Dividend yield
Dividend yield
Average volume
8.97M
Average volume8.97M
High today
$6.74
High today$6.74
Low today
$6.00
Low today$6.00
Open price
$6.02
Open price$6.02
Volume
13.49M
Volume13.49M
52 Week high
$21.73
52 Week high$21.73
52 Week low
$5.02
52 Week low$5.02

Stock Snapshot

Wave Life Sciences(WVE) stock is priced at $6.40, giving the company a market capitalization of 1.2B. It carries a P/E multiple of -5.25.

During the trading session on 2026-03-29, Wave Life Sciences(WVE) shares reached a daily high of $6.74 and a low of $6.00. At a current price of $6.40, the stock is +6.7% higher than the low and still -5.0% under the high.

Trading volume for Wave Life Sciences(WVE) stock has reached 13.49M, versus its average volume of 8.97M.

The stock's 52-week range extends from a low of $5.02 to a high of $21.73.

The stock's 52-week range extends from a low of $5.02 to a high of $21.73.

WVE News

Simply Wall St 16h
Can Wave Life Sciences’ Visceral Fat Data Redefine Its Obesity Strategy Despite Modest Weight Loss?

Earlier this week, Wave Life Sciences reported six‑month Phase 1 INLIGHT data for its investigational obesity therapy WVE‑007, showing reductions in visceral fa...

Can Wave Life Sciences’ Visceral Fat Data Redefine Its Obesity Strategy Despite Modest Weight Loss?
Simply Wall St 2d
Assessing Wave Life Sciences Valuation After Volatile Reaction To WVE-007 Phase 1 Results

Wave Life Sciences (WVE) is back in focus after six month Phase 1 data for its obesity candidate WVE-007 showed reductions in visceral and total fat, yet sparke...

Assessing Wave Life Sciences Valuation After Volatile Reaction To WVE-007 Phase 1 Results
TipRanks 2d
Wave Life Sciences price target lowered to $13 from $27 at Wells Fargo

Wells Fargo lowered the firm’s price target on Wave Life Sciences (WVE) to $13 from $27 and keeps an Overweight rating on the shares. The firm has less convicti...

Analyst ratings

100%

of 18 ratings
Buy
100%
Hold
0%
Sell
0%

More WVE News

Nasdaq 3d
Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints

Wave Life Sciences (NASDAQ:WVE), developer of RNA medicines for rare genetic diseases, closed Thursday at $6.20, down 49.59% for the session. The stock sank aft...

Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints

People also own

Based on the portfolios of people who own WVE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.